Investigating Kidney Disease Risks in Systemic Sclerosis (SSc) - Effects of Proton Pump Inhibitors (PPI): Retrospective Analysis

被引：0
|
作者：
Tskhakaia, Irakli [1 ]
Lau, Arthur [1 ]
机构：
[1] Jefferson Einstein Hosp, Philadelphia, PA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2441
引用
收藏
页码：4950 / 4952
页数：3
相关论文
共 50 条
  • [41] Proton pump inhibitors are associated with increased risk of development of chronic kidney disease
    Pradeep Arora
    Anu Gupta
    Mojgan Golzy
    Nilang Patel
    Randolph L. Carter
    Kabir Jalal
    James W. Lohr
    BMC Nephrology, 17
  • [42] Pharmacoepidemiology for nephrologists: do proton pump inhibitors cause chronic kidney disease?
    Tomlinson, Laurie A.
    Fogarty, Damian G.
    Douglas, Ian
    Nitsch, Dorothea
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 40 - 46
  • [43] Impact of Proton Pump Inhibitors on Kidney Function and Chronic Kidney Disease Progression: A Systematic Review
    Parmar, Mihirkumar P.
    Kaleem, Safa
    Samuganathan, Periyaiyadever
    Ishfaq, Lyluma
    Anne, Tejawi
    Patel, Yashaswi
    Bollu, Sashank
    Vempati, Roopeessh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [44] Effects of vonoprazan and proton pump inhibitors on the efficacy of bevacizumab: a multicentre retrospective study
    Yagi, Kenta
    Maruo, Akinori
    Ishida, Shunsuke
    Aizawa, Fuka
    Ushio, Soichiro
    Sakaguchi, Satoshi
    Kajizono, Makoto
    Niimura, Takahiro
    Goda, Mitsuhiro
    Hamano, Hirofumi
    Izawa-Ishizawa, Yuki
    Zamami, Yoshito
    Ishizawa, Keisuke
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (06) : 2799 - 2804
  • [45] Effects of vonoprazan and proton pump inhibitors on the efficacy of bevacizumab: a multicentre retrospective study
    Kenta Yagi
    Akinori Maruo
    Shunsuke Ishida
    Fuka Aizawa
    Soichiro Ushio
    Satoshi Sakaguchi
    Makoto Kajizono
    Takahiro Niimura
    Mitsuhiro Goda
    Hirofumi Hamano
    Yuki Izawa-Ishizawa
    Yoshito Zamami
    Keisuke Ishizawa
    Clinical and Experimental Medicine, 2023, 23 : 2799 - 2804
  • [46] Proton pump inhibitors and risk of end stage renal disease in patients with chronic kidney disease
    Hsieh, Miyuki Hsing-Chun
    Lai, Edward Chia-Cheng
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 315 - 316
  • [47] Effect of Concomitant Proton Pump Inhibitors with Pazopanib on Cancer Patients: A Retrospective Analysis
    Moreau-Bachelard, Camille
    Letailleur, Valentin
    Bompas, Emmanuelle
    Soulie, Patrick
    Paul, Julie
    Raoul, Jean-Luc
    CANCERS, 2022, 14 (19)
  • [48] Concomitant use of clopidogrel and proton pump inhibitors: A retrospective analysis of prescription behaviour
    Wilkes, Sarah
    van de Wiel, Kayleigh
    Mulder, Kelly
    van Ballegooijen, Hanne
    Zaal, Rianne
    van Der Kuy, Hugo
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2025,
  • [49] Occurrence of Functional Heartburn in Patients with Symptoms of Gastroesophageal Reflux Disease (GERD) Not Responding to Proton Pump Inhibitors (PPI)
    Thomas, Varghese
    Rangan, Kavitha
    Kumar, Sunil
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S25 - S25
  • [50] Systematic review with meta-analysis: the risks of proton pump inhibitors during pregnancy
    Li, Cheng Mei
    Zhernakova, Alexandra
    Engstrand, Lars
    Wijmenga, Cisca
    Brusselaers, Nele
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (04) : 410 - 420
12345